Related Experiment Video
Updated: Nov 12, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
[Anemia as a risk factor of contrast-associated acute kidney injury]
O I Mironova1, A D Deev2, P G Lakotka1
1Sechenov First Moscow State Medical University (Sechenov University).
Insights
Anemia may increase the risk of contrast-associated acute kidney injury (CA-AKI) in patients with coronary artery disease. However, this study did not find a statistically significant link, suggesting further research is needed.
Area of Science:
- Nephrology
- Cardiology
- Hematology
Background:
- Contrast-associated acute kidney injury (CA-AKI) is a significant concern in patients undergoing procedures involving contrast media.
- Anemia is a common comorbidity in patients with coronary artery disease (CAD).
- The potential role of anemia as a risk factor for CA-AKI requires further investigation.
Purpose of the Study:
- To evaluate the association between anemia and the incidence of CA-AKI in patients with stable coronary artery disease.
- To determine if anemia is an independent risk factor for developing CA-AKI post-contrast administration.
Main Methods:
- A prospective cohort study including 1023 patients with chronic coronary artery disease.
- Anemia was present in 83 patients.
- CA-AKI was defined by KDIGO criteria (≥25% or ≥0.5 mg/dl increase in serum creatinine within 48 hours post-contrast).
Main Results:
- CA-AKI developed in 14.5% of patients with anemia based on relative creatinine increase.
- CA-AKI prevalence was 2.4% based on absolute creatinine increase in anemic patients.
- While the rate of CA-AKI was higher in anemic patients (14.4% vs. 12.7%), the difference was not statistically significant (p=0.61).
Conclusions:
- The study observed a higher prevalence of CA-AKI in patients with anemia, but this finding did not reach statistical significance.
- Further research with larger cohorts is warranted to definitively establish the role of anemia in CA-AKI development.
Aim:
The aim of our study was to assess the role of anemia as a risk factor of contrast-associated acute kidney injury (CA-AKI) in patients with stable coronary artery disease.
Materials And Methods:
1023 patients with chronic coronary artery disease were enrolled in a prospective, open, cohort study (ClinicalTrials.gov ID NCT04014153). 83 patients had anemia. CA-AKI was defined as an increase of 25% or more, or an absolute increase of 0.5 mg/dl or more in serum creatinine from baseline value, assessed at 48 hours following the administration of the contrast. The primary endpoint of the study was the development of CA-AKI according to KDIGO criteria.
Results:
CA-AKI developed in 12 (14.5%) patients with anemia according to the relative increase of the level of serum creatinine (25% and more from the baseline). With using the absolute increase of the level of serum creatinine the prevalence of CA-AKI was 2 (2.4%) patients. Patients with anemia had higher rate of CA-AKI than the overall population of the study (14.4% versus 12.7%). Although our results were not statistically significant (р=0.61, odds ratio 1.19, 95% confidence interval 0.632.24).
Conclusion:
The prevalence of CA-AKI was higher in the group of patients with anemia, but didnt meet statistical significance and needs further evaluation in larger studies.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

